Digestive and Liver Disease
Volume 42, Issue 12 , Pages 911-912 , December 2010

Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis

  • Libor Vítek

      Affiliations

    • Institute of Clinical Biochemistry and Laboratory Diagnostics, Prague, Czech Republic
    • 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
    • Corresponding Author InformationCorresponding author at: 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, U Nemocnice 2, Praha 2, 128 08, Czech Republic. Tel.: +420 224 964 203; fax: +420 224 964 203.

References 

  1. EASL Clinical Practice Guidelines. Management of cholestatic liver diseases. J Hepatol 2009;51:237-67.
  2. Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50:291–308
  3. Rudi J, Schonig T, Stremmel W. Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy. Z Gastroenterol. 1996;34:188–191
  4. Brites D, Rodrigues CM. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy. J Hepatol. 1998;29:743–751
  5. Setchel KDR, Lawson AM. Bile acids. In:  Lawson AM editors. Mass spectrometry. Berlin, New York: Walter de Gruyter; 1989;p. 53–125

PII: S1590-8658(10)00208-2

doi: 10.1016/j.dld.2010.06.002

Digestive and Liver Disease
Volume 42, Issue 12 , Pages 911-912 , December 2010

Article Tools